“Liquid Biopsy: The Future of Cancer Detection is in Your Blood”

What if a simple blood test could help detect cancer early, guide treatment, and monitor recurrence—without the need for surgery or painful biopsies?

Welcome to the era of Liquid Biopsy.

🔬 What is a Liquid Biopsy?

It’s a non-invasive blood test that detects cancer-related materials—like circulating tumor DNA (ctDNA), tumor cells, or RNA—released by cancer into the bloodstream.

Unlike traditional biopsies that require a tissue sample, liquid biopsy can be done with just a blood draw.

🎯 Why is it Important?

• Early Detection – especially in cancers like lung, breast, colorectal, and prostate

• Monitoring Treatment Response – see if therapy is working in real time

• Detecting Recurrence Early – ctDNA may rise before any symptoms or scans show changes

• Personalized Treatment – identify actionable mutations for targeted therapies

🧠 What Can It Detect?

• EGFR mutations in lung cancer

• HER2 status in breast cancer

• BRAF in melanoma

• MSI-H or TMB for immunotherapy planning

👨‍⚕️ Is It Available to Everyone?

Not all cancers release enough detectable DNA into the blood, so its use depends on cancer type and stage. It’s best used in conjunction with other diagnostic tools.

💬 What Patients Should Know:

• It’s quick and safe

• May reduce the need for repeat biopsies

• Still evolving – not a complete replacement for tissue biopsy yet

🌟 The Future is PersonalLiquid biopsy brings us closer to a world where cancer care is truly tailored—based on your cancer’s biology, in real time.

📍 At Dr. Rajiv Cancer Clinic, we believe in combining compassion with cutting-edge science to bring you the best of both worlds.

– Dr. Rajiv Mohan, Medical Oncologist